The Human Biome, a developing health frontier (Part 2)
Features Croda International and SkinBioTherapeutics
Small Company Champion: The Human Biome, a developing health frontier (Part 2)
Posted on 26th August 2022 | By Elric Langton
Our second feature in this mini-series on the human microbiome explores skin health, which is far more complex and exciting in terms of addressing important skin health opportunities. In this feature, Elric Langton looks at two very different British companies leading the world in skin care products and science.
You can read the first part of this feature here.
Croda International Plc (LON: CRDA)
Croda International Plc has divested most of its Performance Technologies and Industrial Chemicals businesses recently to a wholly owned subsidiary of Cargill Inc, in a strategic move that positions Croda firmly in consumer care, with a strong focus on the skin healthcare markets, including cosmetics through wholly owned subsidiary Sederma. The divestment means Croda has a war chest of c£667 million, which has a few investors a little nervous about their investment in anothe…